Shenzhen Bioeasy Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 572.09 million compared to CNY 431.07 million a year ago. Revenue was CNY 572.09 million compared to CNY 431.07 million a year ago.

Net income was CNY 148.36 million compared to CNY 195.66 million a year ago. Basic earnings per share from continuing operations was CNY 0.3701 compared to CNY 0.4994 a year ago. Diluted earnings per share from continuing operations was CNY 0.3701 compared to CNY 0.4994 a year ago.